OZEMPIC INJ. (Semaglutide) 0.25mg/0.5mg & 1mg NOVO NORDISK

Ozempic® Injection (semaglutide) is a once-weekly GLP-1 receptor agonist indicated for the management of type 2 diabetes mellitus in adults. It helps improve blood glucose control by stimulating insulin secretion, reducing glucagon release, and slowing gastric emptying, which supports better post-meal glucose regulation. Ozempic® may also aid in weight reduction as part of a comprehensive treatment plan that includes a balanced diet and regular physical activity. Administered via subcutaneous injection, it should be used under the supervision of a qualified healthcare professional to ensure safe and effective therapy.